Back to Search Start Over

COVID-19 Disease and Vitamin D: A Mini-Review.

Authors :
Boulkrane MS
Ilina V
Melchakov R
Fedotova J
Drago F
Gozzo L
Das UN
Abd El-Aty AM
Baranenko D
Source :
Frontiers in pharmacology [Front Pharmacol] 2020 Dec 17; Vol. 11, pp. 604579. Date of Electronic Publication: 2020 Dec 17 (Print Publication: 2020).
Publication Year :
2020

Abstract

Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19.<br />Competing Interests: UD was employed by the company UND Life Sciences LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.<br /> (Copyright © 2020 Boulkrane, Ilina, Melchakov, Fedotova, Drago, Gozzo, Das, Abd El-Aty and Baranenko.)

Details

Language :
English
ISSN :
1663-9812
Volume :
11
Database :
MEDLINE
Journal :
Frontiers in pharmacology
Publication Type :
Academic Journal
Accession number :
33390994
Full Text :
https://doi.org/10.3389/fphar.2020.604579